This book provides information about deadly viruses causing the pandemics in the world and provides clarity about the epidemiology of the diseases. The authors also present information on drug discovery and development as well as diagnosis through Al and machine learning for early detection, prevention, and treatment of various viruses.
This book provides information about the deadly viruses causing the pandemics in the world and provides clarity about the epidemiology of the diseases.
Deadly RNA Viruses: Diagnosis, Detection, and Mitigation of Epidemics and Pandemics presents information about the available drugs, new drug discovery/development, and vaccines against deadly viruses. The international team of contributing authors discusses diagnosis through artificial intelligence and machine learning for early detection, as well as prevention, and treatment of various viruses. The authors also review etiology, epidemiology, and the challenges and limitations of lab research. Finally, the book presents guidelines and road maps to control the diseases, as well implementation and planning strategies to tackle an epidemic.
This book includes exhaustive material regarding various aspects of viruses that have caused pandemics and serve as a good reference and textbook for students and researchers in biotechnology and microbiology.
Chapter 1 Coronavirus (SARS-CoV2)
Chapter 2 Chikungunya
Chapter 3 Dengue
Chapter 4 Ebola
Chapter 5 Hantaviruses
Chapter 6 Hepatitis C Virus
Chapter 7
HIV/AIDS: A deadly viral challenge over the decades
Chapter 8 Influenza
(Spanish flu, H1N1, H5N1) viruses
Chapter 9 Japanese Encephalitis
Chapter 10
Measles
Chapter 11 Rotavirus
Chapter 12 Zika virus
Prof. V. Samuel Raj is a Professor of Microbiology & Biotechnology, Director of the Centre for Drug Design Discovery, and Development (C4D), and Dean of Academic Affairs at SRM University, Delhi-NCR, Haryana, India. He established the Centre for Drug Design Discovery and Development (C4D) at SRM University in 2014. He has more than 10 years of research and development (R&D) experience from two major pharmaceutical giants, Ranbaxy and Daiichi Sankyo, and more than three decades of international and national research experience in infectious diseases including virology. He has made significant contributions in the field of infectious diseases including HIV, dengue, and SARS-CoV-2 (COVID-19). He specializes in R&D in the field of drug discovery with applied clinical outcomes. He leads a team of academicians and researchers who work on containing the pandemic of antimicrobial resistance worldwide.
Dr. V.M. Katoch is a NASI-ICMR Chair in Public Health Research at Rajasthan University of Health Sciences, Jaipur, India, and President of JIPMER, Puducherry, India. He is the former Secretary of the Department of Health Research, Ministry of Health & Family Welfare, and former Director-General of the Indian Council of Medical Research, Government of India, as well as former Director of JALMA, Agra, India. Dr. Katoch is the recipient of various awards and a Fellow of all the National Science Academies in India. As the Founder Secretary of Health Research, Government of India, he played an important role in developing and implementing the Virology Research Laboratories in all the states and medical colleges.
Prof. N.K. Ganguly is the former Director-General of the Indian Council of Medical Research, Government of India; Visiting Professor of Eminence at the Policy Center for Biomedical Research, Translational Health Science & Technology Institute, Faridabad, India; Honorary Senior Research Professor (Clinical Research) at the Institute of Liver & Biliary Sciences, New Delhi, India; Professor at the Ganga Ram Institute for Postgraduate Medical Education & Research, Sir Ganga Ram Hospital, New Delhi; and Distinguished Professor at SRM University, Delhi-NCR, India. His major areas of research have been infectious diseases including viral diseases, cardiovascular diseases and diarrheal diseases. He has been appointed as a member of the Global Work Group of the Advisory Committee to the Director of the Centers for Disease Control, Atlanta, USA.
Lisainfo e-raamatute kohta